BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 109 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,000 | -98.0% | 200 | -99.2% | 0.00% | -100.0% |
| Q1 2020 | $49,000 | +250.0% | 24,433 | +581.2% | 0.00% | +200.0% |
| Q2 2019 | $14,000 | +40.0% | 3,587 | +172.2% | 0.00% | 0.0% |
| Q3 2018 | $10,000 | +42.9% | 1,318 | +64.8% | 0.00% | 0.0% |
| Q1 2017 | $7,000 | -90.0% | 800 | -96.8% | 0.00% | -90.0% |
| Q2 2016 | $70,000 | +311.8% | 24,700 | +311.7% | 0.01% | +400.0% |
| Q1 2016 | $17,000 | +142.9% | 6,000 | +650.0% | 0.00% | +100.0% |
| Q1 2015 | $7,000 | -87.3% | 800 | -82.2% | 0.00% | -87.5% |
| Q4 2014 | $55,000 | +71.9% | 4,500 | +36.4% | 0.01% | +60.0% |
| Q3 2014 | $32,000 | -3.0% | 3,300 | +26.9% | 0.01% | +25.0% |
| Q2 2014 | $33,000 | – | 2,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
| Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
| HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
| Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
| Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
| Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
| Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
| Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |